Back
BioCryst Pharmaceuticals Vs. Novavax Industry Stock Comparison
Sell
29
BCRX
BioCryst Pharmaceuticals
Last Price:
7.35
Seasonality Move:
7.87%
Sell
22
NVAX
Novavax
Last Price:
9.12
Seasonality Move:
7.9%
Sell
29
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy, Sell or Hold?
- The current BioCryst Pharmaceuticals [BCRX] share price is $7.35. The Score for BCRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- BCRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Novavax (NVAX)
is a Sell
Is Novavax a Buy, Sell or Hold?
- The current Novavax [NVAX] share price is $9.12. The Score for NVAX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- NVAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals's stock price today?
-
The BioCryst Pharmaceuticals share price today is $7.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCRX is experiencing slight selling pressure.
NVAX Stock Price Chart
BCRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 42.54 | Sell |
Chaikin Money Flow: | -1116227 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.31 - 8.05) | Sell |
Bollinger Bands (100): | (6.79 - 8.11) | Sell |
NVAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.86 | Sell |
Relative Strength Index (14 RSI): | 31.02 | Sell |
Chaikin Money Flow: | 456843 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.72 - 13.12) | Sell |
Bollinger Bands (100): | (10.99 - 14.35) | Sell |
BCRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.07 | Sell |
20-day SMA: | 7.73 | Sell |
50-day SMA: | 7.84 | Sell |
200-day SMA: | 6.42 | Buy |
8-day EMA: | 7.95 | Sell |
20-day EMA: | 7.85 | Sell |
50-day EMA: | 7.72 | Sell |
200-day EMA: | 7.02 | Buy |
NVAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.74 | Sell |
20-day SMA: | 10.9 | Sell |
50-day SMA: | 11.89 | Sell |
200-day SMA: | 9.8 | Sell |
8-day EMA: | 9.74 | Sell |
20-day EMA: | 10.62 | Sell |
50-day EMA: | 11.59 | Sell |
200-day EMA: | 10.98 | Sell |
BioCryst Pharmaceuticals Earnings Growth & BCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.23 per share.
Novavax Earnings Growth & NVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.07 per share, and an increase next year of $0.60 per share.
BioCryst Pharmaceuticals Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novavax Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |